Scientists are uncovering serotonin’s role in cancer – here’s what we know

Scientists are also exploring how serotonin produced in the gut reaches cancer cells. Understanding this pathway could allow ...
Medical Dialogues

JnJ bags USFDA approval for Caplyta for major depressive disorder

Titusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CAPLYTA ...
Fierce Pharma

J&J's Caplyta supersizes its reach with FDA nod as add-on treatment for major depressive disorder

Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...
Technology Networks

A New Mechanism Behind Psychedelic Therapy's Lasting Effects

Researchers found that the psychedelic compound DOI strengthens connections between the claustrum and anterior cingulate ...
GlobalData on MSN

J&J’s Caplyta wins MDD approval to extend revenue horizon

Caplyta (lumateperone) has scored a label extension into the depression setting, underscoring the belief Johnson & Johnson (J ...

Study suggests 3,000 steps a day is enough to boost brain health. Here’s how

Taking more than 5,000 steps each day could significantly slow cognitive decline and the build-up of proteins associated with ...
Yahoo Malaysia

Neurologist reveals four ways walking can boost your brain

In light of this research, Dr Steven Allder, consultant neurologist at Re:Cognition Health, has highlighted several other key ...
Psychology Today

Genetic Marker Identifies Responders to New Antidepressant

A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.

How walking can boost your brain

New research suggests that walking more than 5,000 steps every day may help slow down cognitive decline and the build-up of a ...